ISMPP Highlights
“In The Know” – Key Updates in Medical Publications
This “In The Know” article highlights various updates in medical publications, to keep professionals apprised of recent developments: a Letter to the Editor about professional medical writers in JAMA Oncology, updated guidance on reporting of race and ethnicity in the AMA Manual of Style, new dates for the 9th Peer Review Congress, and new features in PubMed…
Translations & Presentations of Joint Position Statement Advocating for Pre-Publication Review
AMWA, EMWA, and ISMPP announce the availability of translations into Chinese, Japanese, and Spanish of their Joint Position Statement on Medical Publications, Preprints, and Peer Review, published in CMRO in March 2021. Upcoming presentations in various global regions are also underway…
2021 Member Research, FDA Action for Failure to Submit Clinical Trial Results for Posting, Guideline Updates
Learn from the scientific posters presented at the 2021 European Meeting of ISMPP in January and the 17th Annual Meeting of ISMPP in April. Find out about the first US FDA Notice of Noncompliance for failure to post clinical trial results on ClinicalTrials.gov, as well as an updated PRISMA Statement and a new CONSORT Extension…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
A Company’s Approach to Developing Publication Plain Language Summaries
Scientific publications tend to be written with a specialized audience in mind… Plain language summaries (PLS) of publications represent a way to communicate research more broadly using everyday language. Pfizer recognized this, and in early 2020 implemented a company-wide process for developing PLS…
Pressure in a Pandemic: Lessons for Communicating Scientific Research
Since the global pandemic started, there has been immense pressure to address the threat imposed by COVID-19. Researchers have risen to the challenge and, by working collaboratively, developed effective vaccines and identified some treatment options over an impressively short timescale…
COVID-19 and the Need to Pivot Publication Processes: Sharing a Sponsor’s Experience
In December 2019, the SARS-CoV-2 infection and COVID-19 rapidly spread, afflicting tens of millions of people causing a worldwide pandemic. As of March 2021, approximately 125 million cases have been reported globally with over 2.7 million deaths. This has had a significant impact on medical publication planning…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL RESULTS: Adding an Author at Final Draft Stage?
You are pleased to see that an author of an abstract at final draft has sent her final comments because the submission deadline is just days away. However, the author has also included a request to add one of her colleagues as an author to the abstract…
Find out the Poll Results!
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals